What caused the pre-market volume spike in 7774.T stock today?

The pre-market spike to **532,500.00** shares likely reflects trader reaction to news flow, positioning ahead of the **2026-02-04** earnings date, and short-term technical triggers. High money flow and a rising MACD support momentum, but confirm with company releases before adjusting positions.

How does Meyka AI view 7774.T stock valuation?

Meyka AI notes mixed valuation: **P/E -55.76** and **P/B 4.11** reflect negative earnings and a premium book multiple. The model-grade is **B+ (70.77/100)**, balancing cash strength with profitability risks. This is informational and not investment advice.

What price targets and forecasts exist for 7774.T stock?

Meyka AI's forecast model projects **monthly JPY 605.75** (+3.55% vs **JPY 585.00**) and a **yearly JPY 418.83** (-28.41%). Use these as model-based scenarios only and combine them with company updates and risk management.

Is 7774.T stock liquid enough for active trading today?

Yes. Pre-market volume **532,500.00** exceeded the average **156,254.00**, improving liquidity. Still, biotech moves can be volatile; we advise smaller initial size, limit orders, and stops tied to ATR **JPY 27.69**.

JP Stocks

Heavy volume 09 Jan 2026 7774.T Japan Tissue Engineering (JPX) pre-market: upside

ByDanny Kontos January 8, 2026

7774.T stock opened the pre-market session with a clear volume spike and a JPY 585.00 price, up 9.96% versus the previous close. Volume hit 532,500.00 shares, well above the average of 156,254.00, marking this name as a high-volume mover on the JPX. Traders are watching intraday range JPY 580.00–622.00 and the upcoming earnings date 2026-02-04 for confirmation. We use market data, sector context and technical indicators to explain why this jump matters now for short-term liquidity and medium-term valuation.